NDC 69168-272

Nasal Decongestant PE Maximum Strength Non-Drowsy

Phenylephrine 10 Mg

Nasal Decongestant PE Maximum Strength Non-Drowsy is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Allegiant Health. The primary component is Phenylephrine Hydrochloride.

Product ID69168-272_1b86a209-53b7-455d-b2cd-45f62b6885c2
NDC69168-272
Product TypeHuman Otc Drug
Proprietary NameNasal Decongestant PE Maximum Strength Non-Drowsy
Generic NamePhenylephrine 10 Mg
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-12-23
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart341
Labeler NameAllegiant Health
Substance NamePHENYLEPHRINE HYDROCHLORIDE
Active Ingredient Strength10 mg/1
Pharm ClassesAdrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 69168-272-17

300 TABLET in 1 BOTTLE (69168-272-17)
Marketing Start Date2021-06-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69168-272-93 [69168027293]

Nasal Decongestant PE Maximum Strength Non-Drowsy TABLET
Marketing CategoryOTC MONOGRAPH FINAL
Application Numberpart341
Product TypeHUMAN OTC DRUG
Marketing Start Date2014-12-23
Inactivation Date2020-01-31
Reactivation Date2020-03-13

Drug Details

Active Ingredients

IngredientStrength
PHENYLEPHRINE HYDROCHLORIDE10 mg/1

OpenFDA Data

SPL SET ID:7aef00df-816a-4ea2-a2ad-beed66dd2fe4
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1049182
  • UPC Code
  • 0369168272279

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.